April 09, 2019
Cergentis releases two new application notes: improving QC in cell & gene therapy manufacturing with TLA
March 05, 2019
Cergentis’ TLA technology and Genedata software: efficient in-house data analysis for CHO cell line development
October 02, 2018
New Glenmark paper: TLA and clonal derivation assessment of (CHO) cell lines
September 13, 2018
Cergentis & Princess Máxima Center collaborate on MRD test development for leukemia and solid tumours
June 13, 2018
Cergentis’ CEO invited to present TLA technology at ACTIP meeting in Dusseldorf
